| Event: | Aktiespararna Småbolagsdagen |
| Date: | 03.06.2019 |
| Presentation Time: | Will be provided |
| Address: | Hotel Sheraton, Tegelbacken 6, Stockholm |
| Presenter from Orexo: | CEO Nikolaj Sørensen |
| Other participants from Orexo: | IR Lena Wange |
| Aim: |
Company update. For access to the presentation please contact ir@orexo.com |
| Other: | |
| Contact: | ir@orexo.com |
| External link: | - |
-
About us
About us
Orexo is a fully integrated specialty pharmaceutical company
-
Key Therapeutic Area
Key Therapeutic Area
Opioid addiction is a treatable chronic disease
- Products
-
Pipeline
Pipeline
Embracing all aspects of opioid addiction
-
Sustainability
Sustainability
We will be recognized for the added value our products bring to patients and societies
-
Investors
Investors
Orexo’s share is listed on Nasdaq Stockholm Mid Cap and available as American Depository Receipts (ADRs) on OTCQX in the US.
-
Media
Media
Follow Orexo in social media
